AdBioInk Biosystem Technology

AdBioInk is a leading high-tech startup founded in 2020 with substantial government support and is located within TÜBİTAK Marmara Technopark. Specializing in the biotechnology sector, the company focuses on producing advanced biomaterials, particularly extracellular matrix (ECM) biomaterials including bioink and biopolymers. These materials are designed to accurately replicate the human body, advancing tissue engineering and artificial organ studies by creating an environment that supports cell growth as if within the human body. Moreover, AdBioInk has introduced BioPen, the first handheld bioprinter system, addressing the limitations associated with traditional 3D bioprinters such as the need for a personal computer, specialized user expertise, and high costs. This innovative system allows in-situ applications and is accessible to researchers, revolutionizing the field. In addition to its pioneering bioprinting technology, AdBioInk also developed a user-friendly Uv/Vis curing platform that accommodates light sources with varying wavelengths, enhancing the efficiency and efficacy of research and development processes in biotechnology. The company operates in industries including Biotechnology, Digital Health, Health Care, Health and Wellness, Healthtech, and Life Sciences, with its headquarters located in Turkey. Currently, there is no public information available regarding the last investment or the investors involved with AdBioInk.